Precision OncologyBiotech TrialsPublic · Grade 3ASUSTech AffiliatedNewest Major Hospital in Shenzhen
SUSTech Hospital Precision Medicine & Research, Shenzhen
The teaching hospital of Southern University of Science and Technology — one of China's fastest-rising research universities. Built with purpose-designed research infrastructure, SUSTech Hospital offers precision oncology, active biotech clinical trials, and genomic diagnostics, with shorter waiting times than Shenzhen's older public hospitals. China Care conducts a proxy consultation at SUSTech on your behalf before you travel, then provides bilingual escort and coordination throughout your stay.
Shenzhen, Guangdong — ~30 min from Shenzhen Bao'an Airport; accessible from Shenzhen Bay Port
Quick Facts
Payment
RMB only — paid directly to hospital
Consultation
In-person required for treatment planning
Advance booking
1–2 weeks minimum
Language
Bilingual escort via China Care
Type
Public hospital · Grade 3A · SUSTech affiliated
Grade 3A
National public hospital tier
Newest
Major hospital in Shenzhen
Active
Biotech clinical trial access
NGS
Genomic precision diagnostics
About the Hospital
Shenzhen's Research-Driven Hospital — Where Biotech Meets Clinical Care
SUSTech Hospital (南方科技大学医院) is the affiliated teaching hospital of Southern University of Science and Technology (SUSTech), one of China's most prominent new research universities. SUSTech was founded in 2011 and rapidly achieved global university rankings through its focus on STEM research and international academic collaboration — its hospital inherits the same ethos of rigorous science and rapid innovation.
As Shenzhen's newest major public hospital, SUSTech Hospital was built with modern infrastructure from the ground up. This means state-of-the-art diagnostic equipment, purpose-designed clinical research facilities, and operational workflows that support both standard clinical care and active biotech trials. The hospital has established dedicated precision oncology and genomic medicine units that leverage the university's research capabilities directly.
Patients choosing SUSTech Hospital over Shenzhen's older public hospitals consistently cite two advantages: shorter waiting times for outpatient appointments and diagnostics, and access to cancer treatment clinical trials and precision medicine protocols not yet available at established hospitals. For international patients seeking cutting-edge diagnostics or trial access, SUSTech offers a compelling combination of research depth and operational efficiency.
"Where one of China's fastest-rising research universities meets clinical medicine — precision oncology and biotech trial access within a modern, efficient hospital."
Why Patients Choose SUSTech Hospital
Three reasons international patients choose SUSTech over older Shenzhen hospitals
Shorter Waits, Faster Diagnostics
As Shenzhen's newest major public hospital, SUSTech has not yet accumulated the decades of outpatient demand that creates queues at older institutions. International patients consistently report shorter waiting times for consultations and faster turnaround on diagnostic results — particularly for NGS genomic panels and advanced imaging. For patients who need answers quickly, this operational efficiency is a significant advantage.
Biotech Trial Access Through University Network
SUSTech's university affiliation creates direct access to biotech-sponsored clinical trials not available at stand-alone hospitals. For patients with solid tumours or haematological malignancies who have exhausted standard treatment options, trial eligibility at SUSTech Hospital may open therapeutic avenues unavailable elsewhere in Shenzhen. China Care coordinates trial eligibility review prior to your arrival.
Modern Infrastructure & Research-Grade Diagnostics
Built from the ground up, SUSTech Hospital houses diagnostic equipment and clinical research infrastructure that older hospitals struggle to retrofit. Genomic sequencing, precision imaging, and molecular pathology facilities are purpose-designed rather than adapted. For international patients who have been treated at leading hospitals in the US, UK, or Singapore, the standard of equipment is immediately recognisable.
Clinical Departments
Specialties Available to International Patients
A research-driven hospital with particular strength in precision oncology, genomic diagnostics, and biotech clinical trials. The departments most commonly accessed through China Care are listed below.
Primary Focus
Precision Oncology
Molecularly guided cancer treatment using genomic profiling, circulating tumour DNA analysis, and targeted therapy selection. Protocols individualised based on each patient's tumour genomic signature. Faster diagnostic turnaround than older Shenzhen hospitals.
NGS Tumour ProfilingTargeted TherapyLiquid Biopsy
Primary Focus
Biotech Clinical Trials
Active participation in biotech-sponsored oncology and immunology clinical trials, leveraging SUSTech's university research network. International patients may be eligible to access novel therapies not yet approved in their home countries — eligibility review provided through China Care.
Oncology TrialsImmunotherapyNovel Agents
Also Available
Genomic Medicine
Comprehensive genomic diagnostics including next-generation sequencing (NGS) panels, germline testing, pharmacogenomics, and hereditary cancer risk assessment. Results guide targeted therapy selection and identify patients suitable for trial protocols.
NGS PanelsGermline TestingPharmacogenomics
Also Available
Minimally Invasive Surgery
Laparoscopic and thoracoscopic surgical approaches across gastrointestinal, thoracic, and urological specialties. Newer surgical infrastructure supports high-resolution imaging and precision instrumentation. Reduced recovery times versus open surgery.
LaparoscopicThoracoscopicUrology
Also Available
Preventive Medicine & Screening
Comprehensive health screening using state-of-the-art diagnostic equipment with faster reporting than older public hospitals. Early detection of cardiovascular disease, cancer markers, metabolic conditions, and endocrine disorders.
Cancer MarkersCardiac ScreeningMetabolic Panel
Access via China Care
Not sure if you qualify for a trial?
Submit your records to China Care. We identify appropriate precision oncology protocols or biotech trials at SUSTech, conduct a proxy consultation on your behalf, and confirm eligibility before you travel.
China Care handles your entire referral pathway to SUSTech Hospital, including trial eligibility review where applicable, from initial record submission through to discharge and follow-up.
Step 1
Submit Your Records to China Care
Send your complete records: pathology reports, existing genomic sequencing results (if available), imaging, and treatment history. China Care reviews your records and prepares a bilingual case summary within 1–2 working days. If you are interested in trial access, we flag your case to the clinical trials team simultaneously.
records review · 1–2 days
Step 2
China Care Conducts a Proxy Consultation on Your Behalf
China Care attends SUSTech Hospital in person and consults directly with the relevant specialist — on your behalf, before you travel. The doctor reviews your case summary, indicates whether precision medicine protocols or trial participation are suitable, and gives an initial direction. China Care reports the outcome back to you with voice call interpretation in real time during the consultation.
This service is charged at a fixed fee, covering hospital registration, the in-person proxy consultation, and real-time voice interpretation. Already in China? Skip this step — China Care can arrange direct escort and interpretation for your own visit instead.
Travel to Shenzhen for Your In-Person Consultation
Armed with the specialist's initial direction, you travel to Shenzhen for your own in-person consultation. The specialist reviews your case in person, confirms the treatment plan, and provides a formal cost estimate — this step cannot be completed remotely at a public hospital. China Care's bilingual coordinator accompanies you throughout. For precision oncology cases, NGS genomic profiling is typically initiated at or shortly after this appointment.
in-person consultation · treatment plan & cost estimate issued
Step 4
Admission & Treatment
China Care's coordinator accompanies you through key clinical appointments — particularly for treatment planning discussions, informed consent, and procedural preparation. For patients accessing biotech trial protocols, China Care coordinates all trial documentation, eligibility paperwork, and communications with the research team throughout the process. All treatment fees are paid directly to the hospital in Chinese yuan (RMB). No international credit cards for inpatient treatment. A deposit is required at admission.
China Care on site · RMB payment direct to hospital
Step 5
Discharge, Follow-Up, and Remote Coordination
Upon discharge, patients receive a full bilingual discharge summary including genomic results, treatment summary, and follow-up recommendations. Remote follow-up consultations are available via video for ongoing precision medicine monitoring. China Care coordinates communication between SUSTech Hospital and your home oncology team throughout the post-treatment period.
All fees paid directly to hospital in Chinese yuan. No international credit cards for inpatient treatment. Deposit required at admission.
Advance booking
1–2 weeks minimum
Walk-in not available for international patients. All appointments booked through China Care before you travel.
Consultation type
In-person required
Public hospital. All specialist consultations and treatment planning take place in person. China Care proxy consultation precedes your own visit.
Language
Bilingual escort via China Care
Clinical staff have English-capable researchers due to university environment. China Care provides full interpretation for consultations, treatment discussions, and discharge.
From airport
~30 min from Bao'an Airport
From Shenzhen Bao'an International Airport by taxi or shuttle. Also accessible from Shenzhen Bay Port (cross-border from HK) and Shenzhen North Station (high-speed rail).
Hospital type
Public · Grade 3A
Government-funded teaching hospital. China's highest hospital classification. Treatment costs quoted directly by the hospital — zero markup from China Care.
Common Questions
What patients ask about SUSTech Hospital
What advantages does a university-affiliated research hospital offer over a standard public hospital?
University-affiliated hospitals have formal research partnerships with biotech and pharmaceutical companies, running clinical trials on novel therapies that standard hospitals do not access. They also invest more heavily in precision diagnostics — SUSTech Hospital benefits directly from the university's genomics and biotech research infrastructure. The academic culture means physicians are typically more current on emerging evidence and international guidelines. For patients with complex or treatment-resistant cancers, the combination of research depth and trial access can be decisive.
Can international patients enrol in biotech clinical trials at SUSTech Hospital?
Trial eligibility for international patients depends on the specific protocol's inclusion and exclusion criteria — it is not guaranteed. China Care submits your medical records and genomic data to the trials team at SUSTech Hospital, who assess whether you meet eligibility criteria for any active trials. If you qualify, China Care handles the documentation and coordination. Trial participation may significantly reduce out-of-pocket treatment costs, as investigational drugs are typically provided free of charge within the trial.
What does precision oncology involve at SUSTech Hospital?
Precision oncology at SUSTech Hospital starts with comprehensive genomic profiling of your tumour — typically a large-panel NGS test covering hundreds of cancer-associated genes. The results identify actionable mutations and determine which targeted therapies, immunotherapy agents, or clinical trials you may respond to. Treatment is then selected based on your tumour's molecular profile rather than solely on its location or histological type. This approach is particularly valuable for patients with rare cancers, treatment-resistant tumours, or uncommon mutation profiles.
How much shorter are the wait times compared to Shenzhen's older hospitals?
Exact wait times vary by department and season. As a newer hospital, SUSTech has not yet accumulated the patient load of Shenzhen's established hospitals. International patients working through China Care — where records are translated and submitted in advance — typically experience faster admissions than walk-in patients at any hospital. For time-sensitive oncology cases, the combination of shorter inherent queues and pre-arranged admission through China Care can reduce time-to-treatment significantly.
How does SUSTech Hospital compare to older established hospitals for complex cancer cases?
For complex cases requiring high surgical volume or decades of accumulated specialist experience, older hospitals sometimes hold an advantage in specific procedures. SUSTech Hospital's strengths lie in precision diagnostics, research trial access, newer technology, and operational efficiency. For patients who want molecularly guided treatment, access to novel biotech therapies, or faster diagnostic turnaround, SUSTech is a strong choice. China Care advises each patient on which Shenzhen hospital is most appropriate for their specific diagnosis and treatment goals.
How does payment work at SUSTech Hospital?
All treatment fees are paid directly to SUSTech Hospital in Chinese yuan (RMB). As a public hospital, it does not accept international credit cards for inpatient treatment. A deposit is typically required at admission; the remaining balance is settled before discharge. Payment is made directly to the hospital. China Care does not collect or process medical payments on your behalf; the China Care coordination fee is paid to China Care separately and in advance. We advise patients to arrange RMB exchange before arrival.
Get Started
Ready to enquire about treatment at SUSTech Hospital?
Submit your medical records and genomic data to China Care. We coordinate a clinical review and trial eligibility assessment with the SUSTech Hospital team, typically within 1–2 working days.
China Care coordinates your case with SUSTech Hospital. We handle pre-admission documentation, translation, and trial eligibility review. Treatment costs quoted directly by the hospital — zero treatment markup from China Care.
